Intranasal Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and Clinical Development
出版年份 2018 全文链接
标题
Intranasal Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and Clinical Development
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 12, Pages 3905
出版商
MDPI AG
发表日期
2018-12-07
DOI
10.3390/ijms19123905
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Nose-to-brain peptide delivery – The potential of nanotechnology
- (2018) Eleni Samaridou et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Vaccine Strategies in Gliomas
- (2018) Michael Platten et al. Current Treatment Options in Neurology
- Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics
- (2018) Vassilis Bourganis et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Endoplasmic Reticulum Stress signalling - from basic mechanisms to clinical applications
- (2018) Aitor Almanza et al. FEBS Journal
- Nanosystems in nose-to-brain drug delivery: A review of non-clinical brain targeting studies
- (2018) Patrícia C. Pires et al. JOURNAL OF CONTROLLED RELEASE
- Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs
- (2018) Mukta Agrawal et al. JOURNAL OF CONTROLLED RELEASE
- Intratumoral delivery of bortezomib: impact on survival in an intracranial glioma tumor model
- (2018) Weijun Wang et al. JOURNAL OF NEUROSURGERY
- Mechanism of intranasal drug delivery directly to the brain
- (2018) Tyler P. Crowe et al. LIFE SCIENCES
- NEO212 Inhibits Migration and Invasion of Glioma Stem Cells
- (2018) Nagore I. Marín-Ramos et al. MOLECULAR CANCER THERAPEUTICS
- A Nutritional Perspective of Ketogenic Diet in Cancer: A Narrative Review
- (2018) Camila L.P. Oliveira et al. Journal of the Academy of Nutrition and Dietetics
- Therapeutic Immunization against Glioblastoma
- (2018) Virgil Schijns et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immune Checkpoint Inhibitors for the Treatment of Central Nervous System (CNS) Metastatic Disease
- (2018) Suneel D. Kamath et al. Frontiers in Oncology
- Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa
- (2018) Stella Gänger et al. Pharmaceutics
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
- (2017) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Progress in brain targeting drug delivery system by nasal route
- (2017) Abdur Rauf Khan et al. JOURNAL OF CONTROLLED RELEASE
- Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
- (2017) Michael Weller et al. LANCET ONCOLOGY
- Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data
- (2017) Jann N Sarkaria et al. NEURO-ONCOLOGY
- Personalized cancer vaccines: Targeting the cancer mutanome
- (2017) Xiuli Zhang et al. VACCINE
- Immune Checkpoint Inhibitors in Gliomas
- (2017) Aaron C. Tan et al. Current Oncology Reports
- Efficacy of a ketogenic diet with concomitant intranasal perillyl alcohol as a novel strategy for the therapy of recurrent glioblastoma
- (2017) Juliana Santos et al. Oncology Letters
- Vaccination in the immunotherapy of glioblastoma
- (2017) Ziren Kong et al. Human Vaccines & Immunotherapeutics
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- The endoplasmic reticulum stress/unfolded protein response in gliomagenesis, tumor progression and as a therapeutic target in glioblastoma
- (2016) Natalia M. Peñaranda Fajardo et al. BIOCHEMICAL PHARMACOLOGY
- A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells
- (2016) Niyati Jhaveri et al. CANCER LETTERS
- Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines
- (2016) O. Tu reci et al. CLINICAL CANCER RESEARCH
- An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant Glioma
- (2016) Kenneth D. Swanson et al. Current Neurology and Neuroscience Reports
- Perillyl alcohol efficiently scavenges activity of cellular ROS and inhibits the translational expression of hypoxia-inducible factor-1α via mTOR/4E-BP1 signaling pathways
- (2016) Juan Ma et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Advances in immunotherapy for the treatment of glioblastoma
- (2016) Amanda Tivnan et al. JOURNAL OF NEURO-ONCOLOGY
- The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma
- (2016) F. Bernard-Arnoux et al. NEURO-ONCOLOGY
- The Warburg Effect: How Does it Benefit Cancer Cells?
- (2016) Maria V. Liberti et al. TRENDS IN BIOCHEMICAL SCIENCES
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A novel temozolomide analog, NEO212, with enhanced activity against MGMT-positive melanoma in vitro and in vivo
- (2015) Thomas C. Chen et al. CANCER LETTERS
- Metabolic therapy: A new paradigm for managing malignant brain cancer
- (2015) Thomas N. Seyfried et al. CANCER LETTERS
- Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?
- (2015) A. D. Cox et al. CLINICAL CANCER RESEARCH
- The Role of Glucose Modulation and Dietary Supplementation in Patients With Central Nervous System Tumors
- (2015) Roy E. Strowd et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Inhibition of perillyl alcohol on cell invasion and migration depends on the Notch signaling pathway in hepatoma cells
- (2015) Yong Ma et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Na/K-ATPase as a target for anticancer drugs: studies with perillyl alcohol
- (2015) Diogo Gomes Garcia et al. Molecular Cancer
- Lovastatin and perillyl alcohol inhibit glioma cell invasion, migration, and proliferation – Impact of Ras-/Rho-prenylation
- (2015) Sarah Afshordel et al. PHARMACOLOGICAL RESEARCH
- First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivity
- (2015) Virgil E.J.C. Schijns et al. VACCINE
- Immunotherapy for Brain Cancer: Recent Progress and Future Promise
- (2014) C. M. Jackson et al. CLINICAL CANCER RESEARCH
- The ketogenic diet for the treatment of malignant glioma
- (2014) Eric C. Woolf et al. JOURNAL OF LIPID RESEARCH
- EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
- (2014) Michael Weller et al. LANCET ONCOLOGY
- NEO212, Temozolomide Conjugated to Perillyl Alcohol, Is a Novel Drug for Effective Treatment of a Broad Range of Temozolomide-Resistant Gliomas
- (2014) H.-Y. Cho et al. MOLECULAR CANCER THERAPEUTICS
- A Novel Temozolomide-Perillyl Alcohol Conjugate Exhibits Superior Activity against Breast Cancer Cells In Vitro and Intracranial Triple-Negative Tumor Growth In Vivo
- (2014) T. C. Chen et al. MOLECULAR CANCER THERAPEUTICS
- Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism
- (2014) Bryan G. Allen et al. Redox Biology
- eIF4E-Overexpression imparts perillyl alcohol and rapamycin-mediated regulation of telomerase reverse transcriptase
- (2013) Tabetha Sundin et al. EXPERIMENTAL CELL RESEARCH
- Direct nose to brain drug deliveryviaintegrated nerve pathways bypassing the blood–brain barrier: an excellent platform for brain targeting
- (2013) Chandrakantsing Vijaysing Pardeshi et al. Expert Opinion on Drug Delivery
- Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy
- (2013) Michael Weller et al. INTERNATIONAL JOURNAL OF CANCER
- Disruption of an hTERT–mTOR–RAPTOR protein complex by a phytochemical perillyl alcohol and rapamycin
- (2013) Tabetha Sundin et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Heat-shock protein peptide complex–96 vaccination for recurrent glioblastoma: a phase II, single-arm trial
- (2013) Orin Bloch et al. NEURO-ONCOLOGY
- Immunotherapy of Malignant Gliomas Using Autologous and Allogeneic Tissue Cells
- (2012) F. M. Hofman et al. Anti-Cancer Agents in Medicinal Chemistry
- The isoprenoid perillyl alcohol inhibits telomerase activity in prostate cancer cells
- (2012) Tabetha Sundin et al. BIOCHIMIE
- CHOP is a multifunctional transcription factor in the ER stress response
- (2012) H. Nishitoh JOURNAL OF BIOCHEMISTRY
- Perillyl Alcohol for the Treatment of Temozolomide-Resistant Gliomas
- (2012) H.-Y. Cho et al. MOLECULAR CANCER THERAPEUTICS
- Perillyl alcohol causes G1 arrest through p15INK4b and p21WAF1/Cip1 induction
- (2012) MAKOTO KOYAMA et al. ONCOLOGY REPORTS
- Anatomical and Histological Factors Affecting Intranasal Drug and Vaccine Delivery
- (2012) Sveinbjorn Gizurarson Current Drug Delivery
- Stressed to Death: Targeting Endoplasmic Reticulum Stress Response Induced Apoptosis in Gliomas
- (2011) Guyla G. Johnson et al. CURRENT PHARMACEUTICAL DESIGN
- Preclinical Development of Novel Anti-Glioma Drugs Targeting the Endoplasmic Reticulum Stress Response
- (2011) Axel H. Schonthal et al. CURRENT PHARMACEUTICAL DESIGN
- Glioblastoma survival in the United States before and during the temozolomide era
- (2011) Derek R. Johnson et al. JOURNAL OF NEURO-ONCOLOGY
- Regulating the regulator: post-translational modification of RAS
- (2011) Ian M. Ahearn et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Epidemiology of Brain Metastases
- (2011) Lakshmi Nayak et al. Current Oncology Reports
- Heterogeneous Blood-Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer
- (2010) P. R. Lockman et al. CLINICAL CANCER RESEARCH
- Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas
- (2010) Marc C Chamberlain Expert Review of Neurotherapeutics
- Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma
- (2010) Clovis O. da Fonseca et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy
- (2010) Shailendra Joshi et al. JOURNAL OF NEURO-ONCOLOGY
- The anticancer drug perillyl alcohol is a Na/K-ATPase inhibitor
- (2010) Diogo G. Garcia et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Perillyl alcohol attenuates Ras-ERK signaling to inhibit murine skin inflammation and tumorigenesis
- (2009) Sandeep Chand Chaudhary et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Intranasal delivery to the central nervous system: Mechanisms and experimental considerations
- (2009) Shyeilla V. Dhuria et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Intracarotid Delivery of Drugs
- (2008) Shailendra Joshi et al. ANESTHESIOLOGY
- Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol
- (2008) Clovis Orlando da Fonseca et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- A Pilot Study of Perillyl Alcohol in Pancreatic Cancer
- (2008) Jesus M. Matos et al. JOURNAL OF SURGICAL RESEARCH
- Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas
- (2008) Clovis Orlando da Fonseca et al. SURGICAL NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search